This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: H. Lundbeck A/s. Active years: 2011-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2014
Title: Michel Grenon: Innovator in Pharmaceutical Chemistry
Introduction
Michel Grenon is a notable inventor based in Saddle Brook, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. His work focuses on developing innovative compounds that have potential applications in medicine.
Latest Patents
Among his latest patents, Grenon has developed adamantyl diamide derivatives and their uses. This invention provides adamantyl-diamide derivatives of a specific formula, along with pharmaceutical compositions and methods utilizing these compounds. Another significant patent involves 2-substituted-ethynylthiazole derivatives, which also includes a defined formula and their pharmaceutical applications.
Career Highlights
Michel Grenon is currently associated with H. Lundbeck A/S, a company known for its focus on pharmaceuticals. His work at Lundbeck has allowed him to explore and innovate within the realm of drug development, contributing to advancements in therapeutic options.
Collaborations
Grenon has collaborated with notable colleagues, including Hermogenes N Jimenez and Guiying Li. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Michel Grenon is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His contributions continue to impact the field, showcasing the importance of research and collaboration in developing new medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile